AbbVie Inc
(TSX:ABBV)
C$
35.51
-1.4 (-3.79%)
Market Cap: 592.81 Bil
Enterprise Value: 683.00 Bil
PE Ratio: 123.73
PB Ratio: 0
GF Score: 81/100 Abbvie Inc at JPMorgan Healthcare Conference Transcript
Jan 10, 2024 / 04:15PM GMT
Release Date Price:
C$24.2
(+1.72%)
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst
Good morning, everybody. I'm Chris Schott at JPMorgan and it's my pleasure to be hosting a fireside chat today with AbbVie. From the company, we have Rob Michael, President and Chief Operating Officer; Jeff Stewart, Chief Commercial Officer; Scott Reents, CFO; and Roopal Thakkar, Chief Medical Officer. So thanks, everyone, for joining us today.
Robert A. Michael
AbbVie Inc. - President & COO
Thanks for having us Chris.
Questions & Answers
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst
So Rob, maybe just to kick off, looking at 2024, can you just walk through some of your top priorities and there's been a lot of activity with the company. So how this might change over the course of the last year or so?
Robert A. Michael
AbbVie Inc. - President & COO
The focus for the company is clearly on trying to return to growth in '25, like
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot